Exploiting the therapeutic potential of microRNAs in human cancer

Bibliography

• Cho WC. MicroRNAs: potential biomarkers for cancer diagnosis, prognosis and targets for therapy. Int J Biochem Cell Biol 2010;42:1273-81
   PubMed Web of Science ®Google Scholar
• Cho WC. MicroRNAs in cancer – from research to therapy. Biochim Biophys Acta 2010;1805:209-17
   PubMed Web of Science ®Google Scholar
• Chang S, Wang RH, Akagi K, Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155. Nat Med 2011;17:1275-82
   PubMed Web of Science ®Google Scholar
• Ory B, Ramsey MR, Wilson C, A microRNA-dependent program controls p53-independent survival and chemosensitivity in human and murine squamous cell carcinoma. J Clin Invest 2011;121:809-20
   PubMed Web of Science ®Google Scholar
• Meng F, Glaser SS, Francis H, Functional analysis of microRNAs in human hepatocellular cancer stem cells. J Cell Mol Med 2012;16:160-73
   PubMed Web of Science ®Google Scholar
• Shohet JM, Ghosh R, Coarfa C, A genome-wide search for promoters that respond to increased MYCN reveals both new oncogenic and tumor suppressor microRNAs associated with aggressive neuroblastoma. Cancer Res 2011;71:3841-51
   PubMed Web of Science ®Google Scholar
• Nakahara O, Takamori H, Iwatsuki M, Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2. Ann Surg Oncol 2011; published online 20 Sep 2011; doi:10.1245/s10434-011-2068-6
   Web of Science ®Google Scholar
• Hao Y, Gu X, Zhao Y, Enforced expression of miR-101 inhibits prostate cancer cell growth by modulating the COX-2 pathway in vivo. Cancer Prev Res (Phila) 2011;4:1073-83
   PubMed Web of Science ®Google Scholar
• Saini S, Yamamura S, Majid S, MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res 2011;71:6208-19
   PubMed Web of Science ®Google Scholar
• Wang H, Wu J, Meng X, MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 2011;32:1033-42
   PubMedGoogle Scholar
• Kubo T, Toyooka S, Tsukuda K, Epigenetic silencing of microRNA-34b/c plays an important role in the pathogenesis of malignant pleural mesothelioma. Clin Cancer Res 2011;17:4965-74
   PubMed Web of Science ®Google Scholar
• Alpini G, Glaser SS, Zhang JP, Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol 2011;55:1339-45
   PubMed Web of Science ®Google Scholar
• Cho WC. Targeting the signaling pathways in cancer therapy. Expert Opin Ther Targets 2012;16:1-3
   PubMed Web of Science ®Google Scholar
• Haque I, Banerjee S, Mehta S, Cysteine rich 61-connective tissue growth factor-nephroblastoma-overexpressed 5 (CCN5)/Wnt-1-induced signaling protein-2 (WISP-2) regulates microRNA-10b via hypoxia-inducible factor-1α-TWIST signaling networks in human breast cancer cells. J Biol Chem 2011;286:43475-85
   PubMed Web of Science ®Google Scholar
• Hou J, Lin L, Zhou W, Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinoma. Cancer Cell 2011;19:232-43
   PubMed Web of Science ®Google Scholar
• Sikand K, Slaibi JE, Singh R, miR 488* inhibits androgen receptor expression in prostate carcinoma cells. Int J Cancer 2011;129:810-19
   PubMed Web of Science ®Google Scholar
• Srivastava N, Manvati S, Srivastava A, miR-24-2 controls H2AFX expression regardless of gene copy number alteration and induces apoptosis by targeting antiapoptotic gene BCL-2: a potential for therapeutic intervention. Breast Cancer Res 2011;13:R39
   Web of Science ®Google Scholar
• Liu X, Zhang Z, Sun L, MicroRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4. Carcinogenesis 2011;32:1798-805
   PubMed Web of Science ®Google Scholar
• Wu ZS, Wu Q, Wang CQ, miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer 2011;117:2842-52
   PubMed Web of Science ®Google Scholar
• Hu N, Zhang J, Cui W, miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8. J Biol Chem 2011;286:13714-22
   PubMed Web of Science ®Google Scholar
• Zheng B, Liang L, Wang C, MicroRNA-148a suppresses tumor cell invasion and metastasis by downregulating ROCK1 in gastric cancer. Clin Cancer Res 2011;17:7574-83
   PubMed Web of Science ®Google Scholar
• Takei Y, Takigahira M, Mihara K, The metastasis-associated microRNA miR-516a-3p is a novel therapeutic target for inhibiting peritoneal dissemination of human scirrhous gastric cancer. Cancer Res 2011;71:1442-53
   PubMed Web of Science ®Google Scholar
• Sureban SM, May R, Lightfoot SA, DCAMKL-1 regulates epithelial-mesenchymal transition in human pancreatic cells through a miR-200a-dependent mechanism. Cancer Res 2011;71:2328-38
   PubMed Web of Science ®Google Scholar
• Sun L, Yao Y, Liu B, miR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1. Oncogene 2012;31:432-45
   PubMed Web of Science ®Google Scholar
• Park JK, Kogure T, Nuovo GJ, miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res 2011;71:7608-16
   PubMed Web of Science ®Google Scholar
• Kim M, Kasinski AL, Slack FJ. MicroRNA therapeutics in preclinical cancer models. Lancet Oncol 2011;12:319-21
   PubMed Web of Science ®Google Scholar
• Wiggins JF, Ruffino L, Kelnar K, Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34. Cancer Res 2010;70:5923-30
   PubMed Web of Science ®Google Scholar
• Cho WC. Conquering cancer through discovery research. IUBMB Life 2010;62:645-50
   Web of Science ®Google Scholar